Health TrialsbyHealthPanel

Predicting Pain and Disability From Voice Recordings in Low Back Pain

ConditionChronic Low Back Pain (CLBP)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
Sponsornurmuhammet tas

About this trial

This study aims to investigate whether pain intensity (assessed by Visual Analog Scale - VAS) and functional impairment (Roland-Morris Disability Questionnaire \[RMDQ\] or Oswestry Disability Index \[ODI\]) in patients with chronic low back pain can be estimated using acoustic features extracted from short voice recordings.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age between 18-70 years

Diagnosed with chronic low back pain and attending the physical medicine and rehabilitation clinic

Literate (able to read and write)

Disqualifiers

Age below 18

Illiterate individuals

Trial population

Adults aged 18 to 70 years with chronic low back pain who are literate and visiting the physical medicine and rehabilitation outpatient clinic. Participants must be able to read and speak Turkish fluently to complete questionnaires and perform the standardized reading task for voice recording. Individuals with acute back pain, neurological disorders, or communication impairments are excluded.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Voice Recording Procedure

    Other intervention

    Participants will be asked to read a standardized one-minute text aloud in a quiet room. Their voices will be recorded using a high-quality microphone. The recordings will later be analyzed for acoustic features such as pitch, speech rate, pauses, and intonation. This procedure is non-invasive and does not involve any clinical or pharmacological intervention.

Treatment groups

110 Participants
are divided into 11 treatment groups

11

Treatment groups

See each treatment group below.

Group A: VAS 0 Group1 intervention
Group B: VAS 1 Group1 intervention
Group C: VAS 2 Group1 intervention
Group D: VAS 3 Group1 intervention
Group E: VAS 4 Group1 intervention
Group F: VAS 5 Group1 intervention
Group G: VAS 6 Group1 intervention
Group H: VAS 7 Group1 intervention
Group I: VAS 8 Group1 intervention
Group J: VAS 9 Group1 intervention
Group K: VAS 10 Group1 intervention

Trial outcomes

Primary outcomes

1

Correlation between voice features and pain level (VAS score)

Voice parameters such as pitch, tone, speech rate, and pauses will be analyzed and statistically correlated with pain levels as measured by the Visual Analog Scale (VAS). The VAS is a self-reported pain measurement tool scored on a scale from 0 to 10, where: 0 indicates no pain, and 10 indicates the worst pain imaginable. Higher scores represent worse pain outcomes.

Time frame
At the time of enrollment

Secondary outcomes

1

Correlation between voice features and functional impairment (Oswestry Disability Index [ODI] or Roland-Morris Disability Questionnaire [RMDQ])

Functional disability levels will be assessed using either the Oswestry Disability Index (ODI) or the Roland-Morris Disability Questionnaire (RMDQ) and will be correlated with acoustic voice features such as pitch, tone, speech rate, and pauses. The ODI is scored from 0 to 100, with higher scores indicating greater disability. The RMDQ is scored from 0 to 24, where higher scores also indicate greater disability.

Time frame
At the time of enrollment

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

nurmuhammet tas

Lead sponsor

Erzurum Regional Training & Research Hospital

Sponsor institution

Erzurum Regional Training & Research Hospital

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: